Chu Zhu1, Li Li2, Bin Zhao3. 1. Life Sciences Institute and Innovation Center for Cell Biology, Zhejiang University, Hangzhou 310058, China. 2. Institute of Aging Research, Hangzhou Normal University, Hangzhou 311121, China binzhao@zju.edu.cn lili9981@gmail.com. 3. Life Sciences Institute and Innovation Center for Cell Biology, Zhejiang University, Hangzhou 310058, China binzhao@zju.edu.cn lili9981@gmail.com.
Abstract
The Hippo pathway was initially identified in Drosophila by genetic mosaic screens for tumor suppressor genes. Researches indicated that the Hippo pathway is a key regulator of organ size and is conserved during evolution. Furthermore, studies of mouse models and clinical samples demonstrated the importance of Hippo pathway dysregulation in human cancer development. In addition, the Hippo pathway contributes to progenitor cell and stem cell self-renewal and is thus involved in tissue regeneration. In the Hippo pathway, MST1/2 kinases together with the adaptor protein SAV phosphorylate LATS1/2 kinases. Interaction with an adaptor protein MOB is also important for LATS1/2 activation. Activated LATS1/2 in turn phosphorylate and inhibit Yes-associated protein (YAP). YAP is a key downstream effector of the Hippo pathway, and is a transcriptional co-activator that mainly interacts with TEAD family transcription factors to promote gene expression. Alteration of gene expression by YAP leads to cell proliferation, apoptosis evasion, and also stem cell amplification. In this review, we mainly focus on YAP, discussing its regulation and mechanisms of action in the context of organ size control, tissue regeneration and tumorigenesis.
The Hippo pathway was initially identified in Drosophila by genetic mosaic screens for tumor suppressor genes. Researches indicated that the Hippo pathway is a key regulator of organ size and is conserved during evolution. Furthermore, studies of mouse models and clinical samples demonstrated the importance of Hippo pathway dysregulation in humancancer development. In addition, the Hippo pathway contributes to progenitor cell and stem cell self-renewal and is thus involved in tissue regeneration. In the Hippo pathway, MST1/2 kinases together with the adaptor protein SAV phosphorylate LATS1/2 kinases. Interaction with an adaptor protein MOB is also important for LATS1/2 activation. Activated LATS1/2 in turn phosphorylate and inhibit Yes-associated protein (YAP). YAP is a key downstream effector of the Hippo pathway, and is a transcriptional co-activator that mainly interacts with TEAD family transcription factors to promote gene expression. Alteration of gene expression by YAP leads to cell proliferation, apoptosis evasion, and also stem cell amplification. In this review, we mainly focus on YAP, discussing its regulation and mechanisms of action in the context of organ size control, tissue regeneration and tumorigenesis.
Authors: Gladis Michel-Ramirez; Rogelio Recio-Vega; R Clark Lantz; A Jay Gandolfi; Edgar Olivas-Calderon; Binh T Chau; Mary Kay Amistadi Journal: J Appl Toxicol Date: 2019-10-21 Impact factor: 3.446
Authors: Shama R Iyer; Sameer B Shah; Christopher W Ward; Joseph P Stains; Espen E Spangenburg; Eric S Folker; Richard M Lovering Journal: Am J Physiol Cell Physiol Date: 2019-04-17 Impact factor: 4.249
Authors: Kyeong Hwan Moon; Hyoung-Tai Kim; Dahye Lee; Mahesh B Rao; Edward M Levine; Dae-Sik Lim; Jin Woo Kim Journal: Dev Cell Date: 2017-12-14 Impact factor: 12.270
Authors: Sagar R Shah; Justin M David; Nathaniel D Tippens; Ahmed Mohyeldin; Juan C Martinez-Gutierrez; Sara Ganaha; Paula Schiapparelli; Duane H Hamilton; Claudia Palena; Andre Levchenko; Alfredo Quiñones-Hinojosa Journal: Cell Rep Date: 2017-10-10 Impact factor: 9.423